🟢 GT Biopharma is trading 6.16% up today; catalyst remains unconfirmed

GT Biopharma is trading 6.16% up at $8.94, with today’s specific catalyst unconfirmed.

• Shares rose 39.32% on September 11, following the 1-for-25 reverse split effective September 8.
• The latest listed announcement was a September 11 TriKE platform presentation; no clearly identified new September 14 announcement was found.
• Broader indexes are declining, so market sentiment does not explain today’s gain.